Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral hemorrhage and "ecstasy"].

M Schlaeppi1, A Prica, A de Torrenté

  • 1Département de Médecine Interne, Hôpital Communal, La Chaux-de-Fonds.

Praxis
|May 11, 1999
PubMed
Summary

A young woman experienced acute cerebral hemorrhage after consuming one ecstasy tablet. This case highlights the serious neurological dangers associated with 3,4-methylenedioxymethamphetamine (MDMA) use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma.

Current oncology (Toronto, Ont.)·2019
Same author

Emerging therapies for the treatment of relapsed or refractory follicular lymphoma.

Current oncology (Toronto, Ont.)·2017
Same author

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.

Leukemia & lymphoma·2016
Same author

Monthly blood transfusions decrease after four months of azacitidine.

Vox sanguinis·2015
Same author

Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis.

Neuro-oncology·2014

Area of Science:

  • Neurology
  • Toxicology
  • Emergency Medicine

Background:

  • Recreational drug use, particularly 3,4-methylenedioxymethamphetamine (MDMA, commonly known as "ecstasy"), is prevalent at night parties and "raves."
  • MDMA is associated with various adverse effects, but severe neurological complications are less commonly reported in otherwise healthy individuals.

Observation:

  • A 21-year-old woman with no significant medical history presented with acute neurological deficits.
  • Clinical examination revealed a right-sided sensorimotor syndrome.
  • Neuroimaging, including CT scan and MRI, confirmed a left cerebral hemorrhage.

Findings:

  • The patient's cerebral hemorrhage was directly linked to the ingestion of a single ecstasy tablet.
  • Neurological recovery was incomplete after one year of follow-up, indicating potentially lasting damage.

Implications:

  • This case underscores the critical risk of severe cerebrovascular events, such as cerebral hemorrhage, following MDMA consumption, even in young, healthy individuals.
  • It emphasizes the need for increased awareness among healthcare professionals and the public regarding the potential neurotoxic effects and dangers of MDMA.
  • Further research into the mechanisms underlying MDMA-induced hemorrhagic stroke is warranted to inform prevention and treatment strategies.

Related Experiment Videos